Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 16;11:675873. doi: 10.3389/fonc.2021.675873

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Jia, Niu, Zhu, Wang, Ma and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

RFS_Pem of all patients was summarized. Each row represents one patient. The length of each bar shows the time from start of adjuvant pembrolizumab treatment to the recurrence or the last follow-up. The red triangle indicates patients who developed a recurrence. The numbers and proportions of patients who developed a recurrence at different time points were calculated. The P value was generated from the Chi-Square test to compare the recurrence rates between the IFN-α and no IFN-α groups.